SFCM
VIR icon

Seven Fleet Capital Management’s Vir Biotechnology VIR Stock Holding History

Seven Fleet Capital Management’s Portfolio VIR Stock Details VIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-200
Closed -$1.21K – 136
2025
Q4 		$1.21K Buy
+200
New +$1.19K ﹤0.01% 85

Other funds holding VIR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
SIAU
SB Investment Advisers (UK) London, United Kingdom $7.73B AUM 2.35% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
GP
GSK plc London $599M AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return

Seven Fleet Capital Management's VIR Position: Q1 2026 in Review

Seven Fleet Capital Management sold out of Vir Biotechnology (VIR) in Q1 2026, closing a stake of 200 shares — an estimated $1.21K sold.

Seven Fleet Capital Management first reported a position in VIR in Q4 2025 and held it in 1 quarter. The position peaked at $1.21K in Q4 2025. 251 funds tracked by Wall St. Rank hold VIR as of Q1 2026.

  • Seven Fleet Capital Management reported no remaining Vir Biotechnology position as of Q1 2026 after selling out during the quarter.
  • Seven Fleet Capital Management sold 200 Vir Biotechnology shares in Q1 2026, an estimated $1.21K.
  • Seven Fleet Capital Management first reported a position in Vir Biotechnology in Q4 2025 and held it in 1 quarter.
  • Seven Fleet Capital Management's Vir Biotechnology position peaked at $1.21K in Q4 2025.
  • 251 funds tracked by Wall St. Rank held Vir Biotechnology as of Q1 2026.

Based on Seven Fleet Capital Management's 13F filing for Q1 2026, filed 15 May 2026.